CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $879,236 | -21.9% | 31,949 | -3.7% | 0.00% | 0.0% |
| Q2 2023 | $1,126,035 | -17.3% | 33,187 | -12.4% | 0.00% | -25.0% |
| Q1 2023 | $1,362,383 | -18.6% | 37,865 | +0.8% | 0.00% | -20.0% |
| Q4 2022 | $1,674,317 | +56.8% | 37,566 | -1.1% | 0.01% | +66.7% |
| Q3 2022 | $1,068,000 | -1.7% | 37,980 | -5.8% | 0.00% | 0.0% |
| Q2 2022 | $1,086,000 | -48.2% | 40,299 | -34.6% | 0.00% | -25.0% |
| Q1 2022 | $2,098,000 | +7.1% | 61,600 | +21.5% | 0.00% | 0.0% |
| Q4 2021 | $1,959,000 | -28.4% | 50,700 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $2,737,000 | +64.7% | 50,700 | +2.0% | 0.01% | +100.0% |
| Q2 2021 | $1,662,000 | – | 49,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,132,259 | $30,526,000 | 7.80% |
| Ghost Tree Capital, LLC | 400,000 | $10,784,000 | 5.62% |
| Octagon Capital Advisors LP | 761,398 | $20,527,000 | 5.48% |
| VR Adviser, LLC | 865,116 | $23,324,000 | 4.59% |
| ACUTA CAPITAL PARTNERS, LLC | 267,195 | $7,204,000 | 4.01% |
| COMMODORE CAPITAL LP | 538,812 | $14,526,000 | 3.07% |
| Ikarian Capital, LLC | 616,700 | $16,628,000 | 3.03% |
| TSP Capital Management Group, LLC | 266,545 | $7,186,000 | 2.83% |
| Ikarian Capital, LLC | 537,958 | $14,504,000 | 2.64% |
| Ikarian Capital, LLC | 506,500 | $13,656,000 | 2.49% |